Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    November 24, 2014November 24, 2014

    Study Finds IL28B Polymorphism In Melanoma Patients Is Not A Predictor For Interferon Alpha Treatment

    News
    In a recent study titled “IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma”, published in PlosOne, a team of researchers led by Dr. Katharina Grabmeier-Pfistershammer, ... Read more
    November 21, 2014November 21, 2014

    Study Finds Interactions Between UV Light and Genetic Variants Determinant For Childhood Nevus and Freckles

    News
    In a recent study titled “Interactions between Ultraviolet Light andMC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes”, published in the Cancer Epidemiology, Biomarkers & Prevention journal, a research team ... Read more
    November 20, 2014

    Study Evaluates Solar Elastosis And Cutaneous Melanoma

    News
    In a recent study titled “Solar elastosis and cutaneous melanoma: a site-specific analysis”, published ahead of print in the International Journal of Cancer, a research team led by Dr. David ... Read more
    November 19, 2014November 19, 2014

    Study Finds Combination of Dabrafenib and Trametinib Improves Overall Survival in Metastatic Melanoma Patients

    News
    In a recent article entitled “Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib” published in The New England Journal of Medicine, a team of researchers lead by Caroline ... Read more
    November 17, 2014November 17, 2014

    Bristol-Myers Immunotherapy Opdivo Shows Promising Results In The Treatment Of Advanced Melanoma

    News
    During the Society for Melanoma Research 2014 International Congress in Zurich, Switzerland, Bristol-Myers Squibb (BMS) presented the results of its CheckMate-066 trial, a Phase 3 randomized, double-blind study comparing Opdivo (nivolumab) to ... Read more
    November 14, 2014

    Genetic Testing For Melanoma Risk Could Help With Prevention, According to Study

    News
    A recent study published in the JAMA Dermatology journal, entitled “Family Risk Discussions After Feedback on Genetic Risk of Melanoma” found that positive information on the genetic risk of melanoma ... Read more
    November 13, 2014

    Study Shows Efficacy Of Melanoma Drug TAK-733

    News
    A recent study entitled “Antitumor Activity of the MEK Inhibitor TAK-733 Against Melanoma Cell Lines and Patient-Derived Tumor Explants”, published in the journal Molecular Cancer Therapeutics, investigated the activity of ... Read more
    November 12, 2014

    Tumor Thickness Indicates 10-Year Survival for Mucosal Melanoma

    Melanoma, News
    When thinking of melanoma, skin cancer due to ultraviolet radiation usually comes to mind. Less commonly, about 1% of melanoma patients can develop mucosal melanoma, which is associated with a ... Read more
    November 11, 2014

    OHSU To Host The Community Melanoma Registry

    News
    Oregon Health & Science University will host a half-day symposium at the OHSU Doernbecher Children’s Hospital to discuss the latest melanoma treatments and hear from melanoma survivors. The OHSU Community ... Read more
    November 10, 2014November 10, 2014

    Study Finds Discordancy in BRAF Mutations Among Primary And Metastatic Melanoma Lesions

    News
    One of the commonly used treatments for patients diagnosed with BRAF V600 mutation-positive melanoma with unresectable stage III and IV disease includes selective BRAF inhibitor with or without a MEK ... Read more
    November 7, 2014November 7, 2014

    University of Pittsburgh to Open Multiple Melanoma Tissue Banks

    News
    Human tissue sample banks have been an integral source of research material in the ongoing mission to find better treatments for today’s diseases. These banks house a myriad of samples ... Read more
    November 7, 2014November 7, 2014

    OncoSec To Present Latest Clinical Data at Melanoma Bridge 2014

    News
    During the 2014 Melanoma Bridge meeting in Italy, OncoSec Medical Inc., a company focusing on the development of DNA-based intratumoral cancer immunotherapies, will present its most recent data resultant from ... Read more
    November 6, 2014November 6, 2014

    Study Finds Combination Treatment Effective For Advanced Melanoma

    News
    A recent clinical study titled “Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma: A Randomized Clinical Trial” and published in The Journal of the American Medical Association ... Read more
    November 5, 2014November 5, 2014

    Study Finds Lower Doses of Radiation Therapy Efficient To Treat Uveal Melanomas

    News
    In a recent study titled “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque: An Analysis of Dose on Disease Control and Visual Outcomes”, published in the International Journal of Radiation Oncology.Biology.Physics, ... Read more
    November 4, 2014November 4, 2014

    Study Finds Relatives Of Melanoma Patients Positive For CDKN2A Mutations Have Higher Incidence Of Additional Cancers

    News
    In a recent study titled “Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic ... Read more
    November 3, 2014

    Lymphoseek Receives FDA Expanded Approval For Use In Melanoma and Breast Cancer Lymphatic Mapping

    News
    Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc 99m tilmanocept) injection has received a Food and Drug Administration (FDA) expanded approval for the inclusion of lymphatic mapping in solid tumors and sentinel lymph ... Read more
    October 31, 2014October 31, 2014

    PV-10 Shows Promise In Phase 2 Trial of Advanced Melanoma Patients

    News
    Recent results from Provectus Biopharmaceuticals investigational drug PV-10 have been published in the Annals of Surgical Oncology. A team of research led by Eric A. Wachter, PhD, CTO of Provectus Biopharmaceuticals, ... Read more
    October 30, 2014

    Study Finds Biochemotherapy Effective In High-Risk Melanoma Patients

    News
    A recent report published in the Journal of Clinical Oncology has found that 9 weeks of multiagent biochemotherapy can significantly improve relapse-free survival in patients with high-risk melanoma, when compared ... Read more
    October 29, 2014

    Metastasectomies Following Systemic Treatment Discussed in Panel

    Melanoma, News
    Surgery following systemic therapy against melanoma is a widely discussed topic in the world of clinical oncology. OncLive, a platform of information concerning cancers that include lung, leukemia, and melanoma, ... Read more
    October 28, 2014October 28, 2014

    UV radiation Can Transform Certain Peptides Into Damaging Reactive States

    News
    Exposure to near-UV radiation can lead to several diseases such as cataracts and skin cancer, and since peptides and proteins comprise 68% of the dry matter of cells they are ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.